10.15
8.85%
0.825
Kalvista Pharmaceuticals Inc (KALV) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2024-01-31 | 2023-10-31 | 2023-07-31 | 2023-04-30 | 2023-01-31 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
11.45%
33.15
|
29.75 | 29.09 | 31.73 | 26.95 |
Operating Income/Loss |
11.45%
-33.15
|
-29.75 | -29.09 | -31.73 | -26.95 |
Nonoperating Income/Loss |
96.71%
4.123
|
2.096 | 3.776 | 5.423 | 5.642 |
Income/Loss From Continuing Operations Before Tax |
4.98%
-29.03
|
-27.65 | -25.32 | -26.30 | -21.30 |
Income/Loss From Continuing Operations After Tax |
4.98%
-29.03
|
-27.65 | -25.32 | -26.30 | -21.30 |
Net Income/Loss
|
4.98%
-29.03
|
-27.65 | -25.32 | -26.30 | -21.30 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.46%
34.72
|
34.57 | 34.41 | 2.0805 | 28.28 |
Diluted Average Shares |
0.46%
34.72
|
34.57 | 34.41 | 2.0805 | 28.28 |
Basic Earnings Per Share |
5.00%
-0.84
|
-0.80 | -0.74 | -0.75 | -0.75 |
Diluted Earnings Per Share |
5.00%
-0.84
|
-0.80 | -0.74 | -0.75 | -0.75 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):